News

News

No. Title Written by Date Read
16 Research on STCube’s Small Molecule Immunotherapeutic Agent for Pancreatic Cancer Published in Prestigious Scientific Journal Admin 20.12.09 1
15 STCube, Inc. Obtains U.S. Patent for Proprietary Anti-PD-1 Antibody Admin 20.10.30 1
14 Enter into CDMO Agreement with Samsung Biologics /Eyes of CEO/Hankyung TV Admin 20.08.13 157
13 STCube signs additional development and manufacturing agreement with Samsung Biologics Admin 20.07.12 137
12 STCube Presents Data on Its Proprietary PD-1 Antibody at AACR Admin 20.06.23 212
11 STCube Applies for a U.S. Patent on the COVID-19 Anti-viral Treatment Using 'STT-003' Admin 20.03.30 127
10 STCube Initiates a CRO Contract for Development of COVID-19 Treatment Using ‘STT-003’ Admin 20.03.23 125
9 STCube Publishes Research Paper on Its Antibody to Immune-checkpoint Inhibitor PD-1 in Cancer Research, an International Academic Journal Admin 20.03.12 137
8 STCube and Samsung Biologics Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug Admin 20.03.03 139
7 STCube Obtains EU Patent for Screening Method for Cancer Immunotherapy Candidates Using Radiation Admin 19.11.28 3,388